Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Gain expert guidance on optimal use of biomarkers to guide treatment decisions for advanced NSCLC with this educational program featuring an on-demand webcast and downloadable slidesets from a live CCO webinar along with a podcast of the experts answering questions from the audience.

Share

Program Content

No activities added yet

Activities

NSCLC Biomarkers: Frontline SoC TKIs
Leveraging Established Predictive Biomarkers for Optimal Use of Frontline Targeted Therapies in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2021

Expires: April 13, 2022

NSCLC Biomarkers: Emerging Targeted Therapies
Emerging Predictive Biomarkers for Targeted Therapies in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2021

Expires: April 13, 2022

NSCLC Biomarkers: Overview and IO
Overview of Biomarker Testing in NSCLC and Biomarkers Predicting Response to Immune-Based Therapies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2021

Expires: April 13, 2022

<i>ExpressPoints</i>: NSCLC Biomarkers
ExpressPoints Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 21, 2021

Expires: April 20, 2022

Activities

FAQ: NSCLC Biomarkers
Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: May 19, 2021

Expires: May 18, 2022

Faculty

cover img faculity

Jamie E. Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Stephen Liu, MD

Assistant Professor of Medicine
Department of Medical Oncology
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

cover img faculity

Nathan Pennell, MD, PhD

Professor
Director,
Cleveland Clinic Lung Cancer Medical Oncology Program
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Lilly

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme